Association of IL-10 receptor 2 (IL10RB) SNP with systemic sclerosis

Biochemical and Biophysical Research Communications

Volumn 373, Issue 3, 2008, Pages 403-407

  Hikami, Koki ^a   Ehara, Yukikazu ^b   Hasegawa, Minoru ^c   Fujimoto, Manabu ^c   Matsushita, Masaki ^d   Oka, Takanori ^d   Takehara, Kazuhiko ^c   Sato, Shinichi ^e   Tokunaga, Katsushi ^b   Tsuchiya, Naoyuki ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

^d WAKUNAGA PHARMACEUTICAL CO LTD   (Japan)

^e NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

Genetics; IL 10 receptor; Polymorphism; Systemic sclerosis

Indexed keywords

DNA TOPOISOMERASE; ENZYME ANTIBODY; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 10 RECEPTOR 2;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; SYSTEMIC SCLEROSIS;

ADULT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-10 RECEPTOR BETA SUBUNIT; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SCLERODERMA, DIFFUSE;

EID: 47249110175     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.06.054     Document Type: Article

References (31)

1. Varga J., and Abraham D. Systemic sclerosis: a prototypic multisystem fibrotic disorder. J. Clin. Invest. 117 (2007) 557-567
2. Sato S., Fujimoto M., Hasegawa M., Takehara K., and Tedder T.F. Altered B lymphocyte function induces systemic autoimmunity in systemic sclerosis. Mol. Immunol. 41 (2004) 1123-1133
3. Mayes M.D., and Trojanowska M. Genetic factors in systemic sclerosis. Arthritis Res. Ther. 9 Suppl. 2 (2007) S5
4. Reveille J.D., Owerbach D., Goldstein R., Moreda R., Isern R.A., and Arnett F.C. Association of polar amino acids at position 26 of the HLA-DQB1 first domain with the anticentromere autoantibody response in systemic sclerosis (scleroderma). J. Clin. Invest. 89 (1992) 1208-1213
5. Kuwana M., Kaburaki J., Okano Y., Inoko H., and Tsuji K. The HLA-DR and DQ genes control the autoimmune response to DNA topoisomerase I in systemic sclerosis (scleroderma). J. Clin. Invest. 92 (1993) 1296-1301
6. Fonseca C., Lindahl G.E., Ponticos M., Sestini P., Renzoni E.A., Holmes A.M., Spagnolo P., Pantelidis P., Leoni P., McHugh N., Stock C.J., Shi-Wen X., Denton C.P., Black C.M., Welsh K.I., du Bois R.M., and Abraham D.J. A polymorphism in the CTGF promoter region associated with systemic sclerosis. N. Engl. J. Med. 357 (2007) 1210-1220
7. Tsuchiya N., Kuroki K., Fujimoto M., Murakami Y., Tedder T.F., Tokunaga K., Takehara K., and Sato S. Association of a functional CD19 polymorphism with susceptibility to systemic sclerosis. Arthritis Rheum. 50 (2004) 4002-4007
8. Sato S., Hasegawa M., and Takehara K. Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis. J. Dermatol. Sci. 27 (2001) 140-146
9. Hitomi Y., Tsuchiya N., Hasegawa M., Fujimoto M., Takehara K., Tokunaga K., and Sato S. Association of CD22 gene polymorphism with susceptibility to limited cutaneous systemic sclerosis. Tissue Antigens 69 (2007) 242-249
10. de Waal Malefyt R., Abrams J., Bennett B., Figdor C.G., and de Vries J.E. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174 (1991) 1209-1220
11. Rousset F., Garcia E., Defrance T., Peronne C., Vezzio N., Hsu D.H., Kastelein R., Moore K.W., and Banchereau J. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc. Natl. Acad. Sci. USA 89 (1992) 1890-1893
12. Groux H., Bigler M., de Vries J.E., and Roncarolo M.G. Inhibitory and stimulatory effects of IL-10 on human CD8+ T cells. J. Immunol. 160 (1998) 3188-3193
13. Hasegawa M., Fujimoto M., Kikuchi K., and Takehara K. Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis. J. Rheumatol. 24 (1997) 328-332
14. Crilly A., Hamilton J., Clark C.J., Jardine A., and Madhok R. Analysis of the 5′ flanking region of the interleukin 10 gene in patients with systemic sclerosis. Rheumatology 42 (2003) 1295-1298
15. Beretta L., Cappiello F., Barili M., and Scorza R. Proximal interleukin-10 gene polymorphisms in Italian patients with systemic sclerosis. Tissue Antigens 69 (2007) 305-312
16. Hudson L.L., Rocca K.M., Kuwana M., and Pandey J.P. Interleukin-10 genotypes are associated with systemic sclerosis and influence disease-associated autoimmune responses. Genes Immun. 6 (2005) 274-278
17. Donnelly R.P., Sheikh F., Kotenko S.V., and Dickensheets H. The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain. J. Leukoc. Biol. 76 (2004) 314-321
18. Frodsham A.J., Zhang L., Dumpis U., Taib N.A., Best S., Durham A., Hennig B.J., Hellier S., Knapp S., Wright M., Chiaramonte M., Bell J.I., Graves M., Whittle H.C., Thomas H.C., Thursz M.R., and Hill A.V. Class II cytokine receptor gene cluster is a major locus for hepatitis B persistence. Proc. Natl. Acad. Sci. USA 103 (2006) 9148-9153
19. Lin M.T., Storer B., Martin P.J., Tseng L.H., Grogan B., Chen P.J., Zhao L.P., and Hansen J.A. Genetic variation in the IL-10 pathway modulates severity of acute graft-versus-host disease following hematopoietic cell transplantation: synergism between IL-10 genotype of patient and IL-10 receptor beta genotype of donor. Blood 106 (2005) 3995-4001
20. Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee, Preliminary criteria for the classification of systemic sclerosis (scleroderma), Arthritis Rheum. 23 (1980) 581-590.
21. Staples K.J., Smallie T., Williams L.M., Foey A., Burke B., Foxwell B.M., and Ziegler-Heitbrock L. IL-10 induces IL-10 in primary human monocyte-derived macrophages via the transcription factor Stat3. J. Immunol. 178 (2007) 4779-4785
22. Saito E., Fujimoto M., Hasegawa M., Komura K., Hamaguchi Y., Kaburagi Y., Nagaoka T., Takehara K., Tedder T.F., and Sato S. CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse. J. Clin. Invest. 109 (2002) 1453-1462
23. H2 paradigm. Nat. Rev. Immunol. 4 (2004) 583-594
24. Ong C., Wong C., Roberts C.R., Teh H.S., and Jirik F.R. Anti-IL-4 treatment prevents dermal collagen deposition in the tight-skin mouse model of scleroderma. Eur. J. Immunol. 28 (1998) 2619-2629
25. McGaha T., Saito S., Phelps R.G., Gordon R., Noben-Trauth N., Paul W.E., and Bona C. Lack of skin fibrosis in tight skin (TSK) mice with targeted mutation in the interleukin-4R alpha and transforming growth factor-beta genes. J. Invest. Dermatol. 116 (2001) 136-143
26. Barbarin V., Xing Z., Delos M., Lison D., and Huaux F. Pulmonary overexpression of IL-10 augments lung fibrosis and Th2 responses induced by silica particles. Am. J. Physiol. Lung Cell. Mol. Physiol. 288 (2005) L841-L848
27. Hasegawa M., Fujimoto M., Takehara K., and Sato S. Pathogenesis of systemic sclerosis: altered B cell function is the key linking systemic autoimmunity and tissue fibrosis. J. Dermatol. Sci. 39 (2005) 1-7
28. Sheikh F., Baurin V.V., Lewis-Antes A., Shah N.K., Smirnov S.V., Anantha S., Dickensheets H., Dumoutier L., Renauld J.C., Zdanov A., Donnelly R.P., and Kotenko S.V. Cutting edge: IL-26 signals through a novel receptor complex composed of IL-20 receptor 1 and IL-10 receptor 2. J. Immunol. 172 (2004) 2006-2010
29. Whittington H.A., Armstrong L., Uppington K.M., and Millar A.B. Interleukin-22: a potential immunomodulatory molecule in the lung. Am. J. Respir. Cell Mol. Biol. 31 (2004) 220-226
30. Kotenko S.V., Gallagher G., Baurin V.V., Lewis-Antes A., Shen M., Shah N.K., Langer J.A., Sheikh F., Dickensheets H., and Donnelly R.P. IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex. Nat. Immunol. 4 (2003) 69-77
31. Tan F.K., Zhou X., Mayes M.D., Gourh P., Guo X., Marcum C., Jin L., and Arnett Jr. F.C. Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients. Rheumatology 45 (2006) 694-702